The ADDF offers funding to researchers in both nonprofit and for-profit organizations for drug discovery, clinical trials, and biomarker development. Visit our Research Priorities for specific information about our interests.
ADDF FUNDING PORTAL
The majority of funding is provided through four Core Requests for Proposals (RFPs). Letters of intent are accepted and reviewed on a rolling basis during four cycles each year, with corresponding deadlines for invited full proposals. Check back throughout the year for additional funding opportunities through our collaborations with non-profit, government, and industry partners.
CORE REQUESTS FOR PROPOSALS
Program to Accelerate Clinical Trials (PACT) RFP
Seeks to support Phase 0 through Phase 2 clinical trials, experimental medicine studies in human subjects, and IND-enabling studies.
Biomarkers Development RFP
Seeks to support the development and validation of novel and existing biomarkers that will enhance the design and performance of clinical trials for Alzheimer's disease, related dementias, and cognitive aging.
Prevention Beyond the Pipeline RFP
Seeks to support comparative effectiveness research, prevention clinical trials, and epidemiological studies that probe whether the use or choice of drugs alters the risk for dementia or cognitive decline.
Drug Discovery RFP
Seeks to support programs that advance novel lead molecules to the clinical candidate selection stage, or build preclinical evidence in relevant animal models for repurposed/repositioned drugs.
OTHER ADDF FUNDING OPPORTUNITIES
Supports NIA and NINDS grant proposals in NIH format that were scored but not funded, which fall within our mission and research priorities.
Supports scientific conferences that are relevant to our mission with grants up to $10,000. For more information, email email@example.com with a brief summary of your conference